Identifying underlying causes of immune deficiencies that increase shingles risk

June 12, 2017, JCI Journals

Early life infections with varicella zoster virus cause chickenpox, but the virus can remain dormant in the nervous system for decades and reactivate to cause herpes zoster, commonly known as shingles. Shingles is characterized by a painful skin rash and blisters, and it predominantly affects the elderly. Shingles also occurs at a higher rate in people diagnosed with coronary artery disease (CAD), which affects immune system function in part through changes in infection-responsive immune cells called macrophages. The specific immune mechanisms underlying age- and CAD-related viral reactivation are not well understood.

This week in the JCI, a study led by Cornelia Weyand at Stanford University reports that macrophages derived from individuals diagnosed with CAD suppress the activation and proliferation of T cells. Excessive accumulation of the metabolic intermediate pyruvate in these macrophages increased expression of a signaling molecule called PD-L1 that drives T cell suppression. The overabundance of pyruvate in macrophages suggests that metabolic dysregulation may contribute to immune dysfunction in individuals affected by CAD.

The activity of this immunosuppressive pathway in CAD patients provides insights into a mechanism for immune deficiencies that permit reactivation of long-latent viruses. These findings are a step toward developing new strategies that correct metabolic dysregulation in immune cells to prevent shingles and other infections in at-risk populations.

Explore further: Shingles increases short-term risk of stroke in older adults

More information: Ryu Watanabe et al, Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity, Journal of Clinical Investigation (2017). DOI: 10.1172/JCI92167

Related Stories

Shingles increases short-term risk of stroke in older adults

December 15, 2015
More than 95% of the world's adult population is infected with the virus that causes chickenpox. Up to one third of these individuals will develop shingles (herpes zoster) in their lifetime. A new U.S. study has found that ...

Childhood asthma may increase risks of shingles

December 28, 2015
Nearly 1 million incidences of herpes zoster, which is also known as shingles, occur every year in the U.S., with an estimated one-third of all adults affected by age 80. Despite its prevalence, particularly between ages ...

Viral protein may help chickenpox virus spread within the body

May 25, 2017
The virus that causes chickenpox—varicella zoster virus (VZV)—possesses a protein that could enhance its ability to hijack white blood cells and spread throughout the body, according to new research published in PLOS ...

New study finds shingles vaccine remains effective after chemotherapy

August 5, 2014
The herpes zoster vaccine continues to be effective in protecting older adults against shingles, even after they undergo chemotherapy, according to a Kaiser Permanente study published today in the journal Clinical Infectious ...

Chickenpox vaccine not responsible for rise in shingles, study says

December 2, 2013
(HealthDay)—The prevalence of a painful condition known as shingles is increasing in the United States, but new research says the chickenpox vaccine isn't to blame.

Recommended for you

New, rapid and robust method for single cell profiling

December 17, 2018
Many of the cell types in our bodies work in obscure ways that science does not yet fully understand. That also goes for immune cells, which are vital for protecting us against serious diseases.

Protein police keep the immune system in check

December 17, 2018
Our immune systems defend our bodies against dangerous invaders and help clean up when damage is done. But if our bold protectors are left unsupervised, they sometimes do their jobs too well and end up harming healthy tissues. ...

Probiotic gives long-standing protection against childhood eczema, study finds

December 17, 2018
Giving a probiotic supplement to pregnant mothers and their infants significantly reduces the chances of a child developing eczema for the first 11 years of their life, researchers have shown.

RNA processing and antiviral immunity

December 14, 2018
The RIG-I like receptors (RLRs) are intracellular enzyme sentries that detect viral infection and initiate a first line of antiviral defense. The cellular molecules that activate RLRs in vivo are not clear.

The 'greying' of T cells: Scientists pinpoint metabolic pathway behind age-related immunity loss

December 13, 2018
The elderly suffer more serious complications from infections and benefit less from vaccination than the general population. Scientists have long known that a weakened immune system is to blame but the exact mechanisms behind ...

Scientists create most accurate tool yet developed to predict asthma in young children

December 13, 2018
Scientists at Cincinnati Children's Hospital Medical Center have created and tested a decision tool that appears to be the most accurate, non-invasive method yet developed to predict asthma in young children.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.